Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
了解更多
Webinar: Protein Conformational Analysis Goes High-Throughput with xMAP Technology
Technique provides critical data for development of monoclonal antibodies and biosimilars
At a 2018 xMAP® Connect user group meeting, Xing Wang, President of Array Bridge, spoke about how his team is using xMAP Technology to streamline the development of new biologics and biosimilars for pharma/biotech scientists. The 30-minute presentation focuses on protein conformational analysis (PCA), a multiplex approach that replaces previous testing performed with ELISAs.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
September 26
Luminex Corporation to Present at the Cantor Global Healthcare Conference on
October 2, 2019
September 3
Luminex Corporation to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
July 31
Luminex Corporation Reports Second Quarter 2019 Financial Results And Increase In Quarterly Dividend
July 11
Luminex Corporation Second Quarter Earnings Release Scheduled for July 31, 2019
IDWeek
October 2-6
Washington, D.C.
xMAP® Connect San Diego
October 3
San Diego, CA
